161 related articles for article (PubMed ID: 352939)
1. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
Kaijser B; Larsson P; Olling S
Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
[TBL] [Abstract][Full Text] [Related]
2. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
Mattsby-Baltzer I; Hanson LA; Olling S; Kaijser B
Infect Immun; 1982 Feb; 35(2):647-53. PubMed ID: 7035370
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of immunization with Salmonella minnesota Re 595 against ascending Escherichia coli O6K13H1 pyelonephritis in rats.
Larsson P; Kaijser B; Baltzer IM; Olling S
Scand J Infect Dis Suppl; 1980; Suppl 24():220-3. PubMed ID: 7010560
[TBL] [Abstract][Full Text] [Related]
4. Protection against experimental Proteus mirabilis pyelonephritis in rats and significance of immunity.
Larsson P; Kaijser B; Olling S; Akerlund AS
Acta Pathol Microbiol Scand C; 1978 Oct; 86C(5):215-20. PubMed ID: 31056
[TBL] [Abstract][Full Text] [Related]
5. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
Kaijser B; Larsson P; Olling S; Schneerson R
Infect Immun; 1983 Jan; 39(1):142-6. PubMed ID: 6337094
[TBL] [Abstract][Full Text] [Related]
6. Protection against experimental pyelonephritis by antibodies to pili.
Silverblatt FJ; Weinstein R; Rene P
Scand J Infect Dis Suppl; 1982; 33():79-82. PubMed ID: 6127805
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.
Kumar V; Ganguly Nk; Joshi K; Mittal R; Harjai K; Chhibber S; Sharma S
Med Microbiol Immunol; 2005 Aug; 194(4):211-7. PubMed ID: 15909203
[TBL] [Abstract][Full Text] [Related]
8. Antipili antibody affords protection against experimental ascending pyelonephritis.
Silverblatt FJ; Cohen LS
J Clin Invest; 1979 Jul; 64(1):333-6. PubMed ID: 376560
[TBL] [Abstract][Full Text] [Related]
9. Experimental Escherichia coli ascending pyelonephritis in rats: changes in bacterial properties and the immune response to surface antigens.
Mattsby-Baltzer I; Hanson LA; Kaijser B; Larsson P; Olling S; Svanborg-Edén C
Infect Immun; 1982 Feb; 35(2):639-46. PubMed ID: 7035369
[TBL] [Abstract][Full Text] [Related]
10. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
Infection; 1985; 13 Suppl 2():S256-9. PubMed ID: 3902658
[TBL] [Abstract][Full Text] [Related]
11. Lack of protection against ascending Escherichia coli pyelonephritis in diabetic rats following immunization with purified lipopolysaccharide.
Bryan LE; Schollaardt T; Pak CY; Kim CJ; Yoon JW
Can J Microbiol; 1986 Dec; 32(12):967-9. PubMed ID: 3545411
[TBL] [Abstract][Full Text] [Related]
12. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
Brooks SJ; Lyons JM; Braude AI
Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
[TBL] [Abstract][Full Text] [Related]
13. Pyelonephritis. XIV. Effect of immunization on experimental Escherichia coli pyelonephritis.
Montgomerie JZ; Kalmanson GM; Hubert EG; Guze LB
Infect Immun; 1972 Sep; 6(3):330-4. PubMed ID: 4564890
[TBL] [Abstract][Full Text] [Related]
14. Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.
Ahlstedt S; Kaijser B
Immunology; 1975 May; 28(5):841-6. PubMed ID: 1093966
[TBL] [Abstract][Full Text] [Related]
15. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
[TBL] [Abstract][Full Text] [Related]
16. Peroral immunization of healthy adults with live Escherichia coli O4K12 bacteria. Antibody response as measured in serum and secretions.
Kaijser B
Int Arch Allergy Appl Immunol; 1983; 70(2):164-8. PubMed ID: 6337107
[TBL] [Abstract][Full Text] [Related]
17. Local immune response to Escherichia coli pili in experimental pyelonephritis.
Smith JW; Wagner S; Swenson RM
Infect Immun; 1981 Jan; 31(1):17-20. PubMed ID: 6111536
[TBL] [Abstract][Full Text] [Related]
18. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
[TBL] [Abstract][Full Text] [Related]
19. Divalent flagellin immunotherapy provides homologous and heterologous protection in experimental urinary tract infections in mice.
Sabharwal N; Chhibber S; Harjai K
Int J Med Microbiol; 2016 Jan; 306(1):29-37. PubMed ID: 26655680
[TBL] [Abstract][Full Text] [Related]
20. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
Infection; 1984; 12(4):309-12. PubMed ID: 6386695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
